secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuwellis, Inc. (NUWE)
CIK:        0001506492
Form:       8-K
Filed at:   2025-08-14T23:59:59+00:00
Accession:  0001140361-25-031093
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuwellis Q2 2025 revenue down 23% YoY to $1.7M; net loss widens to $12.6M
-------------------------------------------------------------------------

- Revenue $1.7M vs $2.2M in Q2 2024; decline due to sterilization vendor backorder.
- Gross margin fell to 55.5% from 67.2%; operating loss $2.9M vs $2.3M.
- Net loss attributable to common shareholders $12.6M ($60.99/share) vs $7.7M ($791.82).
- Cash $4.5M; debt-free; completed $5.0M gross capital raise in Q2.
- Outsourced manufacturing to KDI Precision; added two pediatric centers (47 total); new patent on fluid bag design.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506492/000114036125031093/0001140361-25-031093-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506492/000114036125031093/ef20053865_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-031093

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer